Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Asset Writedowns and Impairment (2016 - 2018)

Historic Asset Writedowns and Impairment for Vericel (VCEL) over the last 8 years, with Q4 2018 value amounting to -$303000.0.

  • Vericel's Asset Writedowns and Impairment fell 3060.34% to -$303000.0 in Q4 2018 from the same period last year, while for Sep 2018 it was $71000.0, marking a year-over-year decrease of 9743.87%. This contributed to the annual value of $2.6 million for FY2016, which is 32073.37% up from last year.
  • Latest data reveals that Vericel reported Asset Writedowns and Impairment of -$303000.0 as of Q4 2018, which was down 3060.34% from $537000.0 recorded in Q3 2018.
  • Vericel's 5-year Asset Writedowns and Impairment high stood at $2.5 million for Q4 2016, and its period low was -$303000.0 during Q4 2018.
  • For the 5-year period, Vericel's Asset Writedowns and Impairment averaged around $348857.1, with its median value being $42000.0 (2016).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 4223333.33% in 2016, then crashed by 30895.52% in 2018.
  • Quarter analysis of 5 years shows Vericel's Asset Writedowns and Impairment stood at $2.2 million in 2014, then crashed by 99.73% to $6000.0 in 2015, then skyrocketed by 42233.33% to $2.5 million in 2016, then tumbled by 109.13% to -$232000.0 in 2017, then crashed by 30.6% to -$303000.0 in 2018.
  • Its Asset Writedowns and Impairment was -$303000.0 in Q4 2018, compared to $537000.0 in Q3 2018 and -$140000.0 in Q2 2018.